Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
IKS Health has acquired TruBridge, a healthcare services other business in the United States, for $557M. TruBridge provides healthcare services and related support capabilities that expand IKS Health’s service delivery footprint. IKS Health acquisitions in healthcare M&A focus on adding operational capacity and improving care coordination across healthcare services other offerings. The platform acquisition is classified as a strategic acquisition and is expected to close under Regulation 30, with the announced deal size over $100M.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026